Roble Belko & Company’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-311
Closed -$24K 331
2018
Q2
$24K Sell
311
-85
-21% -$6.38K 0.01% 152
2018
Q1
$27K Buy
396
+132
+50% +$10.1K 0.01% 155
2017
Q4
$20K Buy
264
+215
+439% +$13.8K 0.01% 171
2017
Q3
$3K Hold
49
﹤0.01% 256
2017
Q2
$3K Hold
49
﹤0.01% 256
2017
Q1
$3K Hold
49
﹤0.01% 298
2016
Q4
$3K Hold
49
﹤0.01% 315
2016
Q3
$3K Hold
49
﹤0.01% 271
2016
Q2
$4K Hold
49
﹤0.01% 228
2016
Q1
$3K Hold
49
﹤0.01% 236
2015
Q4
$4K Buy
+49
New +$4.2K ﹤0.01% 183

Other funds holding ESRX

Roble Belko & Company's ESRX Position: Q3 2018 in Review

Roble Belko & Company sold out of Express Scripts Holding Company (ESRX) in Q3 2018, closing a stake of 311 shares — an estimated $24K sold.

Roble Belko & Company first reported a position in ESRX in Q4 2015 and held it in 11 quarters. The position peaked at $27K in Q1 2018. 1,130 funds tracked by Wall St. Rank hold ESRX as of Q3 2018.

  • Roble Belko & Company reported no remaining Express Scripts Holding Company position as of Q3 2018 after selling out during the quarter.
  • Roble Belko & Company sold 311 Express Scripts Holding Company shares in Q3 2018, an estimated $24K.
  • Roble Belko & Company first reported a position in Express Scripts Holding Company in Q4 2015 and held it in 11 quarters.
  • Roble Belko & Company's Express Scripts Holding Company position peaked at $27K in Q1 2018.
  • 1,130 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2018.

Based on Roble Belko & Company's 13F filing for Q3 2018, filed 14 Nov 2018.